Sfoglia per Autore

Mostrati risultati da 1 a 20 di 51
Titolo Data di pubblicazione Autore(i) Tipo File Abstract
Laparoscopic aspiration of ovarian endometriomas : effect with postoperative gonadotropin releasing hormone agonist treatment 1-lug-1992 P. VercelliniG. Bolis + Article (author) -
Gonadotropin releasing hormone agonist treatment before hysterectomy for menorrhagia and uterine leiomyomas 1-lug-1993 P. VercelliniG. Bolis + Article (author) -
Survival of women with advanced ovarian cancer and complete pathologic response at second-look laparotomy 1-gen-1996 G. BolisF. Parazzini + Article (author) -
Case-control study of oestrogen replacement therapy and risk of cervical cancer 1-lug-1997 F. ParazziniC. La VecchiaE. NegriG. Bolis + Article (author) -
Survival and prognostic factors of early ovarian cancer 1-gen-1998 F. ParazziniG. Bolis + Article (author) -
The clinical predictivity of biomarkers of stage III-IV epithelial ovarian cancer in a prospective randomized treatment protocol 1-gen-1998 G. ScarfoneG. Bolis + Article (author) -
Determinants of risk of invasive cervical cancer in young women 1-mar-1998 F. ParazziniC. La VecchiaE. NegriG. Bolis + Article (author) -
Topotecan for the treatment of advanced epithelial ovarian cancer : An open-label phase II study in patients treated after prior chemotherapy that contained cisplatin or carboplatin and paclitaxel 1-ott-1998 G. Bolis + Article (author) -
Chemotherapy in advanced ovarian cancer: four systematic meta-analyses of individual patient data from 37 randomized trials. Advanced Ovarian Cancer Trialists' Group 1-dic-1998 G. Bolis + Article (author) -
A phase I-II trial of high-dose ifosfamide in patients with ovarian cancer refractory or resistant to platinum and/or paclitaxel-containing chemotherapy 1-gen-1999 G. ScarfoneF. ParazziniC. SciattaG. PolverinoG. Bolis + Article (author) -
Paclitaxel vs Epidoxorubicin plus Paclitaxel as Second-Line Therapy for Platinum-Refractory and -Resistant Ovarian Cancer 1-gen-1999 G. BolisF. ParazziniG. Scarfone + Article (author) -
Pelvic and Paraortic Lymph Nodal Status in Advanced Ovarian Cancer and Survival 1-lug-1999 F. ParazziniG. Bolis + Article (author) -
A phase II study of high-dose epirubicin in ovarian cancer patients previously treated with cisplatin 1-ago-2000 G. Bolis + Article (author) -
Site of origin of epithelial ovarian cancer: the endometriosis connection 1-set-2000 P. VercelliniG. ScarfoneG. BolisP.G. Crosignani + Article (author) -
p53 Gene Status and Response to Platinum/Paclitaxel-Based Chemotherapy in Advanced Ovarian Carcinoma 1-dic-2000 G. BolisG. Scarfone + Article (author) -
Phase II study of a combination of cyclophosphamide, adriamycin and cisplatin in advanced fallopian tube carcinoma. An EORTC gynecological cancer group study. European Organization for Research and Treatment of Cancer 1-gen-2001 G. Bolis + Article (author) -
Response and Toxicity to Topotecan in Sensitive Ovarian Cancer Cases with Small Residual Disease after First-Line Treatment with Carboplatinum and Paclitaxel 1-gen-2001 G. BolisG. ScarfoneF. Parazzini + Article (author) -
Role of secondary surgery in relapsed ovarian cancer 1-feb-2001 F. ParazziniG. Bolis + Article (author) -
Carboplatin Alone vs Carboplatin plus Epidoxorubicin as Second-Line Therapy for Cisplatin- or Carboplatin-Sensitive Ovarian Cancer 1-apr-2001 G. BolisG. ScarfoneF. Parazzini + Article (author) -
Clinical Evidence for Topotecan-Paclitaxel Non–Cross-Resistance in Ovarian Cancer 1-apr-2001 G. Bolis + Article (author) -
Mostrati risultati da 1 a 20 di 51
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile